γ-Hydroxybutyrate and the GABAergic footprint: A metabolomic approach to unpicking the actions of GHB

Journal of Neurochemistry

Volumn 115, Issue 1, 2010, Pages 58-67

  Nasrallah, Fatima A ^a   Maher, Anthony D ^a,b   Hanrahan, Jane R ^c   Balcar, Vladimir J ^c   Rae, Caroline D ^a,b  

^a NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

GABA(A)rho; gamma hydroxybutyrate; metabolomics; NMR spectroscopy

Indexed keywords

4 AMINOBUTYRIC ACID CARRIER; 4 AMINOBUTYRIC ACID RECEPTOR; 4 HYDROXYBUTYRIC ACID; BACLOFEN; VIGABATRIN; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID B RECEPTOR; DRUG RECEPTOR; LIGAND; OXYBATE SODIUM; PYRUVIC ACID;

ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; DOSE RESPONSE; GABAERGIC SYSTEM; METABOLOMICS; NONHUMAN; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; ANIMAL; AUTOMATED PATTERN RECOGNITION; DNA FINGERPRINTING; DRUG EFFECTS; GENETICS; GUINEA PIG; IN VITRO STUDY; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; STATISTICAL ANALYSIS;

ANIMALS; CEREBRAL CORTEX; DATA INTERPRETATION, STATISTICAL; DNA FINGERPRINTING; DOSE-RESPONSE RELATIONSHIP, DRUG; GABA PLASMA MEMBRANE TRANSPORT PROTEINS; GAMMA-AMINOBUTYRIC ACID; GUINEA PIGS; IN VITRO TECHNIQUES; LIGANDS; MAGNETIC RESONANCE SPECTROSCOPY; METABOLOMICS; PATTERN RECOGNITION, AUTOMATED; PRINCIPAL COMPONENT ANALYSIS; PYRUVIC ACID; RECEPTORS, DRUG; RECEPTORS, GABA; RECEPTORS, GABA-B; SODIUM OXYBATE;

EID: 77956592294     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2010.06901.x     Document Type: Article

References (94)

1. Addolorato G., Leggio L., Ferrulli A., Caputo F. Gasbarrini A. (2009) The therapeutic potential of gamma-hydroxybutyric acid for alcohol dependence: balancing the risks and benefits. A focus on clinical data. Expert Opin. Investig. Drugs 18, 675 686.
2. Andriamampandry C., Taleb O., Viry S., Muller C., Humbert J. P., Gobaille S., Aunis D. Maitre M. (2003) Cloning and characterization of a rat brain receptor that binds the endogenous neuromodulator γ-hydroxybutyrate (GHB). FASEB J. 17, 1691 1693.
3. Andriamampandry C., Taleb O., Kemmel V., Humbert J. P., Aunis D. Maitre M. (2007) Cloning and functional characterization of a gamma-hydroxybutyrate receptor identified in the human brain. FASEB J. 21, 885 895.
4. 13C NMR spectroscopy. Biochem. J. 266, 133 139.
5. Banerjee P. K. Snead O. C. (1995) Presynaptic gamma-hydroxybutyric acid (GHB) and gamma-aminobutyric acid(B) (GABA(B)) receptor-mediated release of gaba and glutamate (glu) in rat thalamic ventrobasal nucleus (vb) - a possible mechanism for the generation of absence-like seizures induced by GHB. J. Pharmacol. Exp. Ther. 273, 1534 1543.
6. Barbaccia M. L., Carai M. A. M., Colombo G., Lobina C., Purdy R. H. Gessa G. L. (2005) Endogenous gamma-aminobutyric acid (GABA)(A) receptor active neurosteroids and the sedative/hypnotic action of gamma-hydroxybutyric acid (GHB): a study in GHB-S (sensitive) and GHB-R (resistant) rat lines. Neuropharmacology 49, 48 58.
7. Barker J. C., Harris S. L. Dyer J. E. (2007) Experiences of gamma hydroxybutyrate (GHB) ingestion: a focus group study. J. Psychoact. Drugs 39, 115 129.
8. Belelli D., Harrison N. L., Maguire J., Macdonald R. L., Walker M. C. Cope D. W. (2009) Extrasynaptic GABA(A) receptors: form, pharmacology, and function. J. Neurosci. 29, 12757 12763.
9. Bourguignon J. J., Schoenfelder A., Schmitt M., Wermuth C. G., Hechler V., Charlier B. Maitre M. (1988) Analogs of gamma-hydroxybutyric acid - synthesis and binding studies. J. Med. Chem. 31, 893 897.
10. Broer S., Broer A., Schneider H. P., Stegen C., Halestrap A. P. Deitmer J. W. (1999) Characterization of the high-affinity monocarboxylate transporter MCT2 in Xenopus laevis oocytes. Biochem. J. 341, 529 535. (Pubitemid 29389181)
11. Brown N., Kerby J., Bonnert T. P., Whiting P. J. Wafford K. A. (2002) Pharmacological characterisation of a novel cell line expressing human alpha(4)beta(3)delta GABA(A) receptors. Br. J. Pharmacol. 136, 965 974.
12. Caputo F., Vignoli T., Maremmani I., Bernardi M. Zoli G. (2009) Gamma Hydroxybutyric Acid (GHB) for the Treatment of Alcohol Dependence: a Review. Int. J. Environ. Res. Public Health 6, 1917 1929.
13. Carai M. A. M., Colombo G. Gessa G. L. (2005) Resuscitative effect of a gamma-aminobutyric acid B receptor antagonist on gamma-hydroxybutyric acid mortality in mice. Ann. Emerg. Med. 45, 614 619.
14. Carter L. P., Unzeitig A. W., Wu H., Chen W., Coop A., Koek W. France C. P. (2004) The discriminative stimulus effects of gamma-hydroxybutyrate and related compounds in rats discriminating baclofen or diazepam: the role of GABA(B) and GABA(A) receptors. J. Pharmacol. Exp. Ther. 309, 540 547.
15. Carter L. P., Koek W. France C. P. (2009) Behavioral analyses of GHB: receptor mechanisms. Pharmacol. Ther. 121, 100 114.
16. Castelli M. P., Ferraro L., Mocci I., Carta F., Carai M. A. M., Antonelli T., Tanganelli S., Cignarella G. Gessa G. L. (2003) Selective gamma-hydroxybutyric acid receptor ligands increase extracellular glutamate in the hippocampus, but fail to activate G protein and to produce the sedative/hypnotic effect of gamma-hydroxybutyric acid. J. Neurochem. 87, 722 732.
17. Castelli M. P., Pibiri F., Carboni G. Piras A. P. (2004) A review of pharmacology of NCS-382, a putative antagonist of gamma-hydroxybutyric acid (GHB) receptor. CNS Drug Rev. 10, 243 260.
18. Chandra D., Jia F., Liang J. et al. (2006) GABA(A) receptor alpha 4 subunits mediate extrasynaptic inhibition in thalamus and dentate gyrus and the action of gaboxadol. Proc. Natl Acad. Sci. USA 103, 15230 15235.
19. Chebib M. (2004) GABAc receptor ion channels. Clin. Exp. Pharmacol. Physiol. 31, 800 804.
20. Chebib M. Johnston G. A. R. (2000) GABA-activated ligand gated ion channels: medicinal chemistry and molecular biology. J. Med. Chem. 43, 1427 1447.
21. C receptor antagonists. Eur. J. Pharmacol. 329, 223 229.
22. C receptor antagonists. Neuropharmacology 52, 779 787.
23. Cook C. D., Aceto M. D., Coop A. Beardsley P. M. (2002) Effects of the putative antagonist NCS382 on the behavioral pharmacological actions of gammahydroxybutyrate in mice. Psychopharmacology 160, 99 106.
24. Cook C. D., Biddlestone L., Coop A. Beardsley P. M. (2006) Effects of combining ethanol (EtOH) with gamma-hydroxybutyrate (GHB) on the discriminative stimulus, locomotor, and motor-impairing functions of GHB in mice. Psychopharmacology 185, 112 122.
25. Cox D. W. G., Morris P. G., Feeney F. Bachelard H. S. (1983) 31P MRS studies on cerebral energy metabolism under conditions of hypoglycaemia and hypoxia in vitro. Biochem. J. 212, 365 370.
26. 13C labels. J. Neurosci. Res. 66, 771 781.
27. Cui D. P. Morris M. E. (2009) The drug of abuse gamma-hydroxybutyrate is a substrate for sodium-coupled monocarboxylate transporter (SMCT) 1 (SLC5A8): characterization of SMCT-mediated uptake and inhibition. Drug Metab. Dispos. 37, 1404 1410.
28. Davies J. Watkins J. C. (1974) The action of β-phenyl-GABA derivatives on neurones of the cat cerebral cortex. Brain Res. 70, 501 505.
29. Drasbek K. R., Christensen J. Jensen K. (2006) Gamma-hydroxybutyrate - a drug of abuse. Acta Neurol. Scand. 114, 145 156.
30. Drasbek K., Vardya I., Delenclos M., Gibson K. Jensen K. (2008) SSADH deficiency leads to elevated extracellular GABA levels and increased GABAergic neurotransmission in the mouse cerebral cortex. J. Inherit. Metab. Dis. 31, 662 668.
31. Duke R. K., Allan R. D., Chebib M., Greenwood J. R. Johnston G. A. R. (1998) Resolution and conformational analysis of diastereomeric esters of cis and trans-2-(aminomethol)-1-carboxycyclopropanes. Tetrahedron Asymmetry 9, 2533 2548.
32. Eriksson L., Johansson E., Kettaneh-Wold N. Wold S. (1999) Introduction to Multi- and Megavariate Data Analysis Using Projection Methods (PCA and PLS). Umetrics, Umeå, Sweden.
33. Felmlee M. A., Roiko S. A., Morse B. L. Morris M. E. (2010) Concentration-effect relationship for the drug of abuse γ-hydroxybutyric acid. J. Pharmacol. Exp. Ther. 333, 764 771.
34. Froestl W., Mickel S. J., Hall R. G. et al. (1995a) Phosphinic acid analogues of GABA. 1. New potent and selective GABAB agonists. J. Med. Chem. 38, 3297 3312.
35. Froestl W., Mickel S. J., Vonsprecher G. et al. (1995b) Phosphinic acid analogs of GABA. 2. Selective, orally active GABA(B) antagonists. J. Med. Chem. 38, 3313 3331.
36. Glykys J. Mody I. (2007) Activation of GABAA Receptors: views from Outside the Synaptic Cleft. Neuron 56, 763 770.
37. Gobaille S., Hechler V., Andriamampandry C., Kemmel V. Maitre M. (1999) gamma-Hydroxybutyrate modulates synthesis and extracellular concentration of gamma-aminobutyric acid in discrete rat brain regions in vivo. J. Pharmacol. Exp. Ther. 290, 303 309.
38. Godbout R., Jelenic P., Labrie C., Schmitt M. Bourguignon J. J. (1995) Effect of gamma-hydroxybutyrate and its antagonist NCS-382 on spontaneous cell firing in the prefrontal cortex of the rat. Brain Res. 673, 157 160.
39. Gonzalez S. V., Nguyen N. H. T., Rise F. Hassel B. (2005) Brain metabolism of exogenous pyruvate. J. Neurochem. 95, 284 293.
40. 13C NMR. D.Phil., Dept of Biochemistry, The University of Oxford, Oxford.
41. Hanrahan J. R., Mewett K. N., Chebib M., Matos S., Eliopoulos C. T., Crean C., Kumar R. J., Burden P. Johnston G. A. R. (2006) Diastereoselective synthesis of (+/-)-(3-aminocyclopentane)alkylphosphinic acids, conformationally restricted analogues of GABA. Org. Biomol. Chem. 4, 2642 2649.
42. Hechler V., Schmitt M., Bourguignon J. J. Maitre M. (1990) Trans-gamma-hydroxycrotonic acid binding sites in brain - evidence for a subpopulation of gamma hydroxybutyrate sites. Neurosci. Lett. 110, 204 209.
43. Hentschke H., Benkwitz C., Banks M. I., Perkins M. G., Homanics G. E. Pearce R. A. (2009) Altered GABA(A,slow) Inhibition and Network Oscillations in Mice Lacking the GABA(A) Receptor beta(3) Subunit. J. Neurophysiol. 102, 3643 3655.
44. Hosford D. A., Wang Y., Liu C. C. Snead O. C. (1995) Characterization of the antiabsence effects of SCH-50911, a GABA(B) receptor antagonist in the lethargic mouse, gamma-hydroxybutyrate and pentyleneetetrazole models. J. Pharmacol. Exp. Ther. 274, 1399 1403.
45. Howard S. G. Feigenbaum J. J. (1997) Effect of gamma-hydroxybutyrate on central dopamine release in vivo. Biochem. Pharmacol. 53, 103 110.
46. B receptors in mouse neocortical neurons. Cereb. Cortex 11, 424 429.
47. Kato K. (1990) Novel GABAA receptor alpha subunit is expressed only in cerebellar granule cells. J. Mol. Biol. 214, 619 624.
48. Kaupmann K., Cryan J. F., Wellendorph P. et al. (2003) Specific gamma-hydroxybutyrate-binding sites but loss of pharmacological effects of gamma-hydroxybutyrate in GABA(B(1))-deficient mice. Eur. J. Neurosci. 18, 2722 2730.
49. Keros S. Hablitz J. J. (2005) Subtype-specific GABA transporter antagonists synergistically modulate phasic and tonic GABA(A) conductances in rat neocortex. J. Neurophysiol. 94, 2073 2085.
50. Knerr I., Gibson K. M., Jakobs C. Pearl P. L. (2008) Neuropsychiatric morbidity in adolescent and adult succinic semialdehyde dehydrogenase deficiency patients. CNS Spectr. 13, 598 605.
51. Koek W., Carter L. P., Wu H. F., Coop A. France C. P. (2006) Discriminative stimulus effects of flumazenil: perceptual masking by baclofen, and lack of substitution with gamma-hydroxybutyrate and its precursors 1,4-butanediol and gamma-butyrolactone. Behav. Pharmacol. 17, 239 247.
52. Krogsgaardlarsen P., Thyssen K. Schaumburg K. (1978) Inhibitors of GABA uptake - synthesis and H-1 NMR spectroscopic investigations of guvacine (3RS,4SR)-4-hydroxypiperidine-3-carboxylic acid, and related compounds. Acta Chem. Scand. B-Org. Chem. Biochem. 32, 327 334.
53. Kupce E. Freeman R. (1995) Adiabatic pulses for wideband inversion and broadband decoupling. J. Magn. Reson. A 115, 273 276.
54. Le Belle J. E., Harris N. G., Williams S. R. Bhakoo K. K. (2002) A comparison of cell and tissue extraction techniques using high-resolution 1H NMR spectroscopy. NMR Biomed. 15, 37 44.
55. Li Q., Kuhn C. M., Wilson W. A. Lewis D. V. (2007) Effects of gamma hydroxybutyric acid on inhibition and excitation in rat neocortex. Neuroscience 150, 82 92.
56. Lingenhoehl K., Brom R., Heid J., Beck P., Froestl W., Kaupmann K., Bettler B. Mosbacher J. (1999) gamma-Hydroxybutyrate is a weak agonist at recombinant GABA(B) receptors. Neuropharmacology 38, 1667 1673.
57. Madden T. E. Johnson S. W. (1998) Gamma-hydroxybutyrate is a GABA(B) receptor agonist that increases a potassium conductance in rat ventral tegmental dopamine neurons. J. Pharmacol. Exp. Ther. 287, 261 265.
58. Maitre M. (1997) The γ-hydroxybutyrate signalling system in brain. Organization and functional implications. Prog. Neurobiol. 51, 337 361.
59. Maitre M., Hechler V., Vayer P., Gobaille S., Cash C. D., Schmitt M. Bourguignon J. J. (1990) A specific gammahydroxybutyrate receptor ligand possesses both antagonistic and anticonvulsant properties. J. Pharmacol. Exp. Ther. 255, 657 663.
60. Mamelak M. (2009) Narcolepsy and depression and the neurobiology of gammahydroxybutyrate. Prog. Neurobiol. 89, 193 219.
61. Mathivet P., Bernasconi R., DeBarry J., Marescaux C. Bittiger H. (1997) Binding characteristics of gamma-hydroxybutyric acid as a weak but selective GABA(B) receptor agonist. Eur. J. Pharmacol. 321, 67 75.
62. McIlwain H. Bachelard H. (1985) Biochemistry and the Central Nervous System. Churchill Livingstone, Edinburgh.
63. Molnar T., Antal K., Nyitrai G. Emri Z. (2009) Gamma-hydroxybutyrate (GHB) induces GABA(B) receptor independent intracellular Ca2 + transients in astrocytes, but has no effect on GHB or GABA(B) receptors of medium spiny neurons in the nucleus accumbens. Neuroscience 162, 268 281.
64. Morris M. E. Felmlee M. A. (2008) Overview of the proton-coupled MCT (SLC16A) family of transporters: characterization, function and role in the transport of the drug of abuse gamma-hydroxybutyric acid. Aaps J. 10, 311 321.
65. Moussa C. E.-H., Rae C., Bubb W. A., Griffin J. L., Deters N. A. Balcar V. J. (2007) Inhibitors of glutamate transport modulate distinct patterns in brain metabolism. J. Neurosci. Res. 85, 342 350.
66. Nasrallah F., Griffin J. L., Balcar V. J. Rae C. (2007) Understanding your inhibitions. Modulation of brain cortical metabolism by GABA-B receptors. J. Cereb. Blood Flow Metab. 27, 1510 1520.
67. Nasrallah F., Griffin J. L., Balcar V. J. Rae C. (2009) Understanding your inhibitions. Effects of GABA and GABAA receptors on brain cortical metabolism. J. Neurochem. 108, 57 71.
68. Nasrallah F. A., Balcar V. J. Rae C. (2010) A metabonomic study of inhibition of GABA uptake in the cerebral cortex. Metabolomics 6, 67 77.
69. van Nieuwenhuijzen P. S. McGregor I. S. (2009) Sedative and hypothermic effects of gamma-hydroxybutyrate (GHB) in rats alone and in combination with other drugs: assessment using biotelemetry. Drug Alcohol Depend. 103, 137 147.
70. Olah S., Fule M., Komlosi G., Varga C., Baldi R., Barzo P. Tamas G. (2009) Regulation of cortical microcircuits by unitary GABA-mediated volume transmission. Nature 461, 1278 U1113.
71. B receptor antagonist in rat neocortical slices. Eur. J. Pharmacol. 362, 35 41.
72. Pearl P. L., Gibson K. M., Acosta M. T. et al. (2003) Clinical spectrum of succinic semialdehyde dehydrogenase deficiency. Neurology 60, 1413 1417.
73. Pedraza C., Garcia F. B. Navarro J. F. (2009) Neurotoxic effects induced by gammahydroxybutyric acid (GHB) in male rats. Int. J. Neuropsychopharmacol. 12, 1165 1177.
74. Rae C., Lawrance M. L., Dias L. S., Provis T., Bubb W. A. Balcar V. J. (2000) Strategies for studies of potentially neurotoxic mechanisms involving deficient transport of L-glutamate: antisense knockout in rat brain in vivo and changes in the neurotransmitter metabolism following inhibition of glutamate transport in guinea pigs brain slices. Brain Res. Bull. 53, 373 381.
75. 13C NMR spectroscopy and metabolomic study. J. Neurochem. 92, 405 416.
76. Rae C., Moussa C. E.-H., Griffin J. L., Parekh S. B., Bubb W. A., Hunt N. H. Balcar V. J. (2006) A metabolomic approach to ionotropic glutamate receptor subtype function: a nuclear magnetic resonance in vitro investigation. J. Cereb. Blood Flow Metab. 26, 1005 1017.
77. Rae C., Nasrallah F. A., Griffin J. L. Balcar V. J. (2009) Now I know my ABC. A systems neurochemistry and functional metabolomic approach to understanding the GABAergic system. J. Neurochem. 109 (Suppl. 1 109 116.
78. C receptor antagonist. Mol. Pharmacol. 50, 1024 1030.
79. Schmidt-Mutter C., Pain L., Sandner G., Gobaille S. Maitre M. (1998) The anxiolytic effect of gamma-hydroxybutyrate in the elevated plus maze is reversed by the benzodiazepine receptor antagonist, flumazenil. Eur. J. Pharmacol. 342, 21 27.
80. Schweitzer P., Roberto M., Madamba S. G. Siggins G. R. (2004) gamma-hydroxybutyrate increases a potassium current and decreases the H-current in hippocampal neurons via GABA(B) receptors. J. Pharmacol. Exp. Ther. 311, 172 179.
81. Skinner T. E. Bendall M. R. (1997) A phase-cycling algorithm for reducing sidebands in adiabatic decoupling. J. Magn. Reson. 124, 474 478.
82. Suzdak P. D., Frederiksen K., Andersen K. E., Sorensen P. O., Knutsen L. J. Nielsen E. B. (1992) NNC-711, a novel potent and selective gamma-aminobutyric acid uptake inhibitor: pharmacological characterization. Eur. J. Pharmacol. 224, 189 198.
83. Tagamets M. A. Horwitz B. (2001) Interpreting PET and fMRI measures of functional neural activity: the effects of synaptic inhibition on cortical activation in human imaging studies. Brain Res. Bull. 54, 267 273.
84. Tancredi D. N., Shannon M. W., Goldstein J. N., Kosowsky J., Lai M. Singh M. K. (2003) A man with sudden alteration of mental status - Ingestion of 1,4-butanediol, resulting in gamma-hydroxybutyrate intoxication. New Engl. J. Med. 349, 1267 1275.
85. Tarasenko A. S., Linetska M. V., Storchak L. G. Himmelreich N. H. (2006) Effectiveness of extracellular lactate/pyruvate for sustaining synaptic vesicle proton gradient generation and vesicular accumulation of GABA. J. Neurochem. 99, 787 796.
86. Ticku M. K. Mehta A. K. (2008) Characterization and pharmacology of the ghb receptor, in Drug Addiction: Research Frontiers and Treatment Advances (Kuhar M. J., ed.), Vol. 1139, pp. 374 385. Blackwell Publishing, Oxford.
87. Vayer P., Dessort D., Bourguignon J. J., Wermuth C. G., Mandel P. Maitre M. (1985) Natural occurrence of trans-gamma hydroxycrotonic acid in rat brain. Biochem. Pharmacol. 34, 2401 2404.
88. Wall M. J. (2001) Cis-4-amino-crotonic acid activates [alpha]6 subunit-containing GABAA but not GABAC receptors in granule cells of adult rat cerebellar slices. Neurosci. Lett. 316, 37 40.
89. Wisden W., Laurie D. J., Monyer H. Seeburg P. H. (1992) The distribution of 13 GABA-A receptor subunit messenger-RNAs in the rat brain. 1. Telencephalon, Diencephalon, Mesencephalon. J. Neurosci. 12, 1040 1062.
90. Wold S., Antti H., Lindgren F. Ohman J. (1998) Orthogonal signal correction of near-infrared spectra. Chemom. Intell. Lab. Syst. 44, 175 185.
91. Wong G. Skolnick P. (1992) High-affinity ligands for diazepam-insensitive benzodiazepine receptors. Eur. J. Pharmacol.-Mol. Pharmacol. Sect. 225, 63 68.
92. Woodman R. J. McIlwain H. (1961) Glutamic acid, other amino acids and related compounds as substrate for cerebral tissues - their effects on tissue phosphates. Biochem. J. 81, 83.
93. Zvosec D. L. Smith S. W. (2005) Agitation is common in gamma-hydroxybutyrate toxicity. Am. J. Emerg. Med. 23, 316 320.
94. 13C isotopomer analysis of glucose and alanine metabolism reveals cytosolic pyruvate compartmentation as part of energy metabolism in astrocytes. Glia 34, 200 212.